With 91% sensitivity but only 25% specificity, the tool is worthwhile for clinicians who remain wary of frequent false positives that would send patients with no fractures for unneeded imaging.

Experts found that compared to the average effective doses of organs, breast doses were higher, representing increased risks of breast cancer for women. 

A pharmaceutical compound approved 21 years ago to treat breast cancer in postmenopausal women is showing fresh promise as a therapy for glioblastomas. 

The boon comes in the form of greater brain cortical thickness observable on neonatal MRI two weeks after the baby enters the world.

Researchers in the U.K. have documented fetuses smiling when exposed to sweet flavors and frowning over bitter tastes.

Interventional radiology patients who receive this type of patient decision aid for consent purposes tend to feel more heard and better informed.

Shockwave announced at TCT 2022 that it hopes to enroll up to 400 patients for a new all-female clinical trial.

A machine learning system has come along that needs no human labeling of data for training yet matches radiologists at classifying diseases on chest X-rays—including some that the model was not specifically taught to detect.